A Clinical Trial to Evaluate the Safety and Efficacy of IBS Angel in Patients With Pulmonary Artery Stenosis

NARecruitingINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

July 13, 2021

Primary Completion Date

July 31, 2024

Study Completion Date

December 31, 2025

Conditions
Pulmonary Artery Stenosis
Interventions
DEVICE

Iron Bioresorbable Scaffold System (IBS Angel)

Subjects in this arm will be implanted with IBS Angel.

Trial Locations (10)

Unknown

NOT_YET_RECRUITING

The Second Xiangya Hospital of Central South University, Changsha

NOT_YET_RECRUITING

Children's Hospital of Chongqing Medical University, Chongqing

RECRUITING

The People's Hospital of Gaozhou, Gaozhou

RECRUITING

Guangdong Provincial People's Hospital, Guangzhou

NOT_YET_RECRUITING

Fuwai Yunnan Cardiovascular Hospital, Kunming

NOT_YET_RECRUITING

Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

NOT_YET_RECRUITING

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

NOT_YET_RECRUITING

General Hospital of Northern Theater Command of Chinese People's Liberation Army, Shenyang

NOT_YET_RECRUITING

Shenzhen Children's Hospital, Shenzhen

NOT_YET_RECRUITING

Fuwai Central China Cardiovascular Hospital, Zhengzhou

All Listed Sponsors
lead

Biotyx Medical (Shenzhen) Co., Ltd.

INDUSTRY